Sandoz Lawsuit Vs. European Commission Highlights Uncertainties Over Biogenerics
In a case likely to have broad implications, Swiss generic drug maker Sandoz has filed a lawsuit against the European Commission for denying approval of the world's first generic biotech drug....To view the full article, register now.
Already a subscriber? Click here to view full article